Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657
Janier M [Syphilis (except congenital syphilis)]. 1999 Aug-Sep Ann Dermatol Venereol pmid:10530355
Schmidtke LM and Carson J Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. 1999 Vet. Microbiol. pmid:10535774
Tobback K et al. Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. 1999 J Chromatogr A pmid:10536850
Maeda K et al. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10540836
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Netherwood T et al. Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. 1999 Appl. Environ. Microbiol. pmid:10543832
Jobe DA et al. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. 1999 Clin. Diagn. Lab. Immunol. pmid:10548588
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Malonza IM et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. 1999 J. Infect. Dis. pmid:10558945
Reeves AR et al. Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. 1999 J. Bacteriol. pmid:10559177
Denis A et al. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. 1999 Bioorg. Med. Chem. Lett. pmid:10560728
Bauer JF et al. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. 1999 J Pharm Sci pmid:10564073
Morel P et al. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. 1999 Clin. Exp. Dermatol. pmid:10564319
Matsuoka M et al. Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. 1999 FEMS Microbiol. Lett. pmid:10564793
Menezes CM et al. In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. 1999 Jul-Aug Rev. Inst. Med. Trop. Sao Paulo pmid:10564920
Melo-Cristino J and Fernandes ML Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. 1999 Microb. Drug Resist. pmid:10566873
Clarke AE et al. Interaction of bile with erythromycin Lactobionate in vitro. 1975 Aust N Z J Med pmid:1057910
Peng L and Nimni ME Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. 1999 J. Pharm. Pharmacol. pmid:10579684
Brown MS et al. Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. 1999 J. Antibiot. pmid:10580387
Klausner MA Astemizole use with erythromycin. 1999 Ann. Allergy Asthma Immunol. pmid:10582723
Zarazaga M et al. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. 1999 Antimicrob. Agents Chemother. pmid:10582908
McCrea J et al. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. 1999 J Clin Pharmacol pmid:10586386
Durak H et al. Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. 1999 Nucl. Med. Biol. pmid:10587109
Varaldo PE et al. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. 1999 Clin. Infect. Dis. pmid:10589905
Glass D et al. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. 1999 Dermatology (Basel) pmid:10592405
Brixius B et al. [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. 1999 Nov-Dec Klin Padiatr pmid:10592929
Damkier P et al. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. 1999 Br J Clin Pharmacol pmid:10594487
Doumith M et al. Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. 1999 Mol. Microbiol. pmid:10594828
Portillo A et al. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. 1999 Int. J. Antimicrob. Agents pmid:10595574
Sugiyama Y et al. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. 1999 Eur. Respir. J. pmid:10596699
Polk RE et al. Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. 1999 Pharmacotherapy pmid:10600086
Esposito S et al. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. 2000 Jan-Feb Chemotherapy pmid:10601794
Ku YY et al. Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. 1999 J. Antibiot. pmid:10604761
Ianaro A et al. Anti-inflammatory activity of macrolide antibiotics. 2000 J. Pharmacol. Exp. Ther. pmid:10604943
Sato Y et al. Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine. 1999 Cell. Immunol. pmid:10607432
Wang JS et al. Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. 1999 Pharmacol. Toxicol. pmid:10608481
Honein MA et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. 1999 Dec 18-25 Lancet pmid:10609814
Czeizel AE et al. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. 1999 Nov-Dec Reprod. Toxicol. pmid:10613401
Chieppa DM et al. Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. 2000 Eur. J. Clin. Invest. pmid:10620004
Novikova SI et al. Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. 2000 FEMS Microbiol. Lett. pmid:10620668
Desaki M et al. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. 2000 Biochem. Biophys. Res. Commun. pmid:10623585
Kdesh A et al. Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. 1999 South. Med. J. pmid:10624910
García Sánchez MJ et al. [Bacterial resistances]. 1999 Aten Primaria pmid:10630037
Sullivan S et al. Stevens-Johnson syndrome secondary to erythromycin. 1999 Ann Pharmacother pmid:10630839
Trinkle R Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. 1999 Ann Pharmacother pmid:10630842
Puri SK and Singh N Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. 2000 Exp. Parasitol. pmid:10631075
Weston WL and Morelli JG Steroid rosacea in prepubertal children. 2000 Arch Pediatr Adolesc Med pmid:10632252
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. 1999 MMWR Morb. Mortal. Wkly. Rep. pmid:10634345

Table of Content